ExxonMobil reported strong third-quarter earnings and free cash flow driven by high petroleum prices and refinery margins amid geopolitical tensions. The company announced a $20 billion stock buyback for next year and increased its dividend by 4%, signaling confidence in capital returns. Production growth in the Permian Basin and favorable macroeconomic conditions support a 'Strong Buy' rating, though risks include potential slowing volume growth and falling crude prices. These results suggest potential for new all-time highs in ExxonMobil's stock.
ExxonMobil's recent earnings and buyback plans provide context for energy market activity. For readers following energy stocks, here is Pluang's market snapshot as of Nov 02, 2026 19:11 WIB: Of 79 priced energy-sector US stocks tradable on Pluang, 19 rose and 55 fell today. Notable movers include UEC at USD 7.90 (+2.46%), VG at USD 14.43 (-2.43%), and PTEN at USD 13.01 (-2.33%).
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
